BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31309733)

  • 1. Responsiveness of the Patient-Reported Outcomes Measurement Information System Global Health Short Form in Outpatients With Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1282-1288. PubMed ID: 31309733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2018 Mar; 45(3):397-404. PubMed ID: 29419473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    Kasturi S; Szymonifka J; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    J Rheumatol; 2017 Jul; 44(7):1024-1031. PubMed ID: 28412708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus.
    Jones JT; Carle AC; Wootton J; Liberio B; Lee J; Schanberg LE; Ying J; Morgan DeWitt E; Brunner HI
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):133-142. PubMed ID: 27111350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE.
    Devilliers H; Amoura Z; Besancenot JF; Bonnotte B; Pasquali JL; Wahl D; Maurier F; Kaminsky P; Pennaforte JL; Magy-Bertrand N; Arnaud L; Binquet C; Guillemin F; Bonithon-Kopp C
    Rheumatology (Oxford); 2015 May; 54(5):940-9. PubMed ID: 25361539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Patient-Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive tests in systemic lupus erythematosus outpatients.
    Kasturi S; Burket JC; Berman JR; Kirou KA; Levine AB; Sammaritano LR; Mandl LA
    Lupus; 2018 Sep; 27(10):1591-1599. PubMed ID: 29793381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study.
    Louthrenoo W; Kasitanon N; Morand E; Kandane-Rathnayake R
    Arthritis Res Ther; 2020 Jan; 22(1):8. PubMed ID: 31924267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus Erythematosus.
    McElhone K; Abbott J; Sutton C; Mullen M; Lanyon P; Rahman A; Yee CS; Akil M; Bruce IN; Ahmad Y; Gordon C; Teh LS
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1505-13. PubMed ID: 26816223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus.
    Mahieu MA; Ahn GE; Chmiel JS; Dunlop DD; Helenowski IB; Semanik P; Song J; Yount S; Chang RW; Ramsey-Goldman R
    Lupus; 2016 Oct; 25(11):1190-9. PubMed ID: 26869353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosus.
    Giangreco D; Devilliers H; Annapureddy N; Block JA; Jolly M
    Lupus; 2015 Dec; 24(14):1486-91. PubMed ID: 26162686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus Erythematosus.
    Nantes SG; Strand V; Su J; Touma Z
    Arthritis Care Res (Hoboken); 2018 Jan; 70(1):125-133. PubMed ID: 28320078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in quality of life in relation to disease activity in systemic lupus erythematosus: post-hoc analysis of the BLISS-52 Trial.
    Jolly M; Annapureddy N; Arnaud L; Devilliers H
    Lupus; 2019 Dec; 28(14):1628-1639. PubMed ID: 31674267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus.
    Katz P; Pedro S; Michaud K
    Arthritis Care Res (Hoboken); 2017 Sep; 69(9):1312-1321. PubMed ID: 28029753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Validation of the Lupus Impact Tracker: A Patient-Completed Tool for Clinical Practice to Evaluate the Impact of Systemic Lupus Erythematosus.
    Jolly M; Kosinski M; Garris CP; Oglesby AK
    Arthritis Rheumatol; 2016 Jun; 68(6):1422-31. PubMed ID: 26814452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL.
    Lai JS; Beaumont JL; Jensen SE; Kaiser K; Van Brunt DL; Kao AH; Chen SY
    Clin Rheumatol; 2017 Mar; 36(3):555-562. PubMed ID: 27848056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
    Touma Z; Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
    Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
    Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.
    Devilliers H; Bonithon-Kopp C; Jolly M
    Lupus; 2017 Apr; 26(4):396-402. PubMed ID: 27587460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings.
    Schneider M; Mosca M; Pego-Reigosa JM; Gunnarsson I; Maurel F; Garofano A; Perna A; Porcasi R; Devilliers H
    Rheumatology (Oxford); 2017 May; 56(5):818-828. PubMed ID: 28204765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus.
    Petri M; Kawata AK; Fernandes AW; Gajria K; Greth W; Hareendran A; Ethgen D
    J Rheumatol; 2013 Nov; 40(11):1865-74. PubMed ID: 24085548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.